Identity
- Security key
- 21495
- Ticker
- SEPN
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-10-25
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- SEPN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $2,249,362,075.93
- Shares outstanding (class)
- 45,075,533
- Shares outstanding (weighted)
- 46,676,947
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 130
- Location
- SOUTH SAN FRANCISCO, CA
- Homepage
- https://www.septerna.com
- Description
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.